|
G |
Abcc8 |
ATP-binding cassette, sub-family C member 8 |
multiple interactions |
ISO |
[KCNJ11 mutant form co-treated with ABCC8 mutant form] results in increased susceptibility to Gliclazide |
CTD |
PMID:22209866 |
|
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
|
|
G |
Akr1c18 |
aldo-keto reductase family 1, member C18 |
decreases activity |
ISO |
Gliclazide results in decreased activity of AKR1C3 protein |
CTD |
PMID:26362498 |
|
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
|
|
G |
Alb |
albumin |
affects binding multiple interactions |
ISO |
Gliclazide binds to ALB protein Gliclazide inhibits the reaction [[Streptozocin co-treated with Cholesterol, Dietary] results in increased secretion of ALB protein] |
CTD |
PMID:14871415 PMID:20974553 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein] |
CTD |
PMID:18088078 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression |
ISO |
Gliclazide inhibits the reaction [Glucose results in increased expression of CASP3 protein] Gliclazide inhibits the reaction [Acetic Acid results in increased expression of CASP3 protein] Gliclazide results in decreased expression of CASP3 mRNA |
CTD |
PMID:18088078 PMID:32045587 PMID:33652124 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in decreased activity of CAT protein]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of CAT protein]; Gliclazide inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:20307516 PMID:20643114 PMID:21439372 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
EXP |
Gliclazide inhibits the reaction [Hydrogen Peroxide results in increased expression of CDKN1A mRNA] |
CTD |
PMID:12646174 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] |
CTD |
PMID:28330423 |
|
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC protein] |
CTD |
PMID:21439372 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Glo1 |
glyoxalase 1 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] |
CTD |
PMID:21439372 |
|
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in decreased activity of GSR protein]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GSR protein] |
CTD |
PMID:20307516 PMID:21439372 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] |
CTD |
PMID:21439372 |
|
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
Gliclazide inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA] Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of HMOX1 protein] |
CTD |
PMID:12646174 PMID:21439372 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Cholesterol, Dietary] results in increased expression of ICAM1 protein]; Gliclazide inhibits the reaction [Acetic Acid results in increased expression of ICAM1 protein] |
CTD |
PMID:14871415 PMID:32045587 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of IL10 protein] |
CTD |
PMID:32045587 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of IL1B protein]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of IL1B protein]; Gliclazide inhibits the reaction [Streptozocin results in increased expression of IL1B protein] |
CTD |
PMID:20307516 PMID:20643114 PMID:21439372 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of IL6 protein]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of IL6 protein]; Gliclazide inhibits the reaction [Acetic Acid results in increased expression of IL6 protein]; Gliclazide inhibits the reaction [Streptozocin results in increased expression of IL6 protein] |
CTD |
PMID:20307516 PMID:20643114 PMID:21439372 PMID:32045587 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Streptozocin results in decreased expression of and results in decreased secretion of INS1 protein]; Gliclazide inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:28330423 PMID:28625491 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
multiple interactions |
ISO |
[KCNJ11 mutant form co-treated with ABCC8 mutant form] results in increased susceptibility to Gliclazide |
CTD |
PMID:22209866 |
|
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 protein] |
CTD |
PMID:21439372 |
|
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:32045587 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:32045587 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:32045587 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in increased activity of MPO protein] |
CTD |
PMID:32045587 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Cholesterol, Dietary] results in increased expression of NCF1 protein] |
CTD |
PMID:14871415 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] |
CTD |
PMID:21439372 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
increases expression |
ISO |
Gliclazide results in increased expression of NOS3 protein |
CTD |
PMID:14871415 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [Acetic Acid results in decreased expression of PPARG protein] |
CTD |
PMID:32045587 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of RELA protein]; Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of RELA protein]; Gliclazide inhibits the reaction [Streptozocin results in increased expression of RELA protein] |
CTD |
PMID:20307516 PMID:20643114 PMID:21439372 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
multiple interactions |
ISO |
Gliclazide inhibits the reaction [[Streptozocin co-treated with Cholesterol, Dietary] results in decreased expression of SOD2 protein] |
CTD |
PMID:14871415 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
Gliclazide inhibits the reaction [[Niacinamide co-treated with Streptozocin] results in increased expression of TNF protein]; Gliclazide inhibits the reaction [Streptozocin results in increased expression of TNF protein] Gliclazide results in decreased expression of TNF protein |
CTD |
PMID:20307516 PMID:20643114 PMID:21439372 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
multiple interactions |
EXP |
Gliclazide inhibits the reaction [Hydrogen Peroxide results in increased expression of TNFAIP3 mRNA] |
CTD |
PMID:12646174 |
|
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression |
ISO |
Gliclazide results in increased expression of TP53 mRNA |
CTD |
PMID:33652124 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|